Phase I/II ECHO-202/KEYNOTE-037: Safety of Epacadostat + Pembrolizumab in Solid Tumors

Slideset - In a phase II expansion study, the combination had a low incidence of grade 3/4 adverse events across all tumor types evaluated.
Source: Clinical Care Options Breast Cancer - Category: Cancer & Oncology Source Type: research